Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Replimune Group, Inc. Director's Dealing 2020

Dec 10, 2020

33193_dirs_2020-12-09_769d7e96-aa67-45f4-bf8d-fa8cc6a75a78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-12-08

Reporting Person: SLATTERY JOSEPH P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-08 Common Stock M 5200 $3.30 Acquired 11867 Direct
2020-12-08 Common stock S 5200 $46.00 Disposed 6667 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-08 Stock Option (right to buy) $3.30 M 5200 Disposed 2027-10-01 Common Stock (5200) Direct

Footnotes

F1: 25% of the shares underlying this stock option vested on October 1, 2018 and the remainder of the shares underlying this stock option vest in 36 equal monthly installments thereafter.